TSCO
44
-4
BMY
55
-8
MAR
63
-5
HCP
56
-8
SLG
57
-3
JNPR
50
-6
ORLY
60
-5
PEP
39
-9
YUM
43
-6
ESS
62
-3
KMX
61
-3
BSX
64
-3
WMB
68
2
BA
47
2
GOOG
57
-6
FOX
51
-6
CA
22
-3
SJM
9
-5
RL
69
-4
MCD
52
-5
TSCO
44
-4
BMY
55
-8
MAR
63
-5
HCP
56
-8
SLG
57
-3
JNPR
50
-6
ORLY
60
-5
PEP
39
-9
YUM
43
-6
ESS
62
-3
KMX
61
-3
BSX
64
-3
WMB
68
2
BA
47
2
GOOG
57
-6
FOX
51
-6
CA
22
-3
SJM
9
-5
RL
69
-4
MCD
52
-5
Financhill
Back

Morgan Stanley Emerging Markets Domestic Debt Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
41

EDD
Morgan Stanley Emerging Markets Domestic Debt Fund

Last Price:
4.63
Seasonality Move:
1.54%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
41
Morgan Stanley Emerging Markets Domestic Debt Fund (EDD) is a Sell

Is Morgan Stanley Emerging Markets Domestic Debt Fund a Buy, Sell or Hold?

  • The current Morgan Stanley Emerging Markets Domestic Debt Fund [EDD] share price is $4.64. The Score for EDD is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • EDD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDD Stock Price Chart

What is Morgan Stanley Emerging Markets Domestic Debt Fund's stock price today?

  • The Morgan Stanley Emerging Markets Domestic Debt Fund share price today is $4.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDD is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 37.52 Sell
Chaikin Money Flow: 166862 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.67 - 4.85) Sell
Bollinger Bands (100): (4.73 - 5.01) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.71 Sell
20-day SMA: 4.73 Sell
50-day SMA: 4.89 Sell
200-day SMA: 4.78 Sell
8-day EMA: 4.68 Sell
20-day EMA: 4.74 Sell
50-day EMA: 4.82 Sell
200-day EMA: 4.79 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Morgan Stanley Emerging Markets Domestic Debt Fund Earnings Growth & EDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Morgan Stanley Emerging Markets Domestic Debt Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):